AskEdgar

this is what's coming with the new AskEdgar agent. a real query a small-cap trader ran on $OTLK this morning after their FDR win PR dropped: "can you provide the chronological history of this dispute? trying to find out times when OTLK may have gapped down on this news because they released this PR this morning so maybe it's resolved now." the agent ran 2 news searches, 6 price history queries, built a chronological FDA dispute timeline going back to August 2023, mapped each CRL to the corresponding gap-down event, and then did the analytical work: it confirmed both gap-downs stemmed from the same FDA complaint ("insufficient substantial evidence of effectiveness"), confirmed today's FDR reversal addresses that exact deficiency, and flagged 4 risks the PR doesn't address, including a cash position of $7.7M, a float that's expanded from ~30.9M to ~87M+ shares since the gap-downs, and the Class 1 vs Class 2 resubmission downgrade risk. An analyst spends 2-4 hours on this exact workflow. our agent did it in 7.9 seconds.

Premarket Movers: $YMAT (+218.54% | $1.45): Received authorization today from the Central Bank of Taiwan for a $60 million sovereign-backed loan to build a 100MWh solid-state battery manufacturing facility in Texas. $PHGE (+94.73% | $1.59): No new catalyst today, but shares are surging on speculative retail momentum following the company's recent strategic pivot from biotech to Israeli defense and AI technology. $QTEX (+93.99% | $1.42): No new catalyst today, but momentum continues following last week's announcement of advanced partnership discussions with a top-five global quantum computing company. $OTLK (+90.19% | $0.59): Won its FDA appeal today via the Formal Dispute Resolution process, clearing the path to resubmit the Biologics License Application for its wet AMD treatment, LYTENAVA. $MNTS (+74.80% | $12.94): No new catalyst today, but the low-float space stock is experiencing retail momentum and carryover sentiment from recent NASA contract updates. (SpaceX sympathy) $ARTL (+52.39% | $1.82): No new catalyst today, but the micro-cap biotech is seeing a technical relief rally and momentum trading following mid-May pipeline updates. $UZX (+47.23% | $0.66): No new catalyst today, but retail interest remains high following its recent ticker change and strategic pivot to integrate crypto and AI into its e-commerce platform (formerly $LGCB) $NXXT (+31.30% | $1.14): Announced a $6.4 million private placement today with a single institutional investor to support growth, adding to momentum from record April revenues. $IQST (+27.27% | $1.54): No new catalyst today, but shares continue to run on momentum from last week's strong Q1 earnings report showing 70% year-over-year revenue growth. $HTT (+21.31% | $3.02): Initiated a modified Dutch auction tender offer today to repurchase up to 39 million of its American Depositary Shares at $2.80 to $3.20 per share. $CPSH (+20.83% | $7.21): No new catalyst today, but the stock is seeing continued retail buying and momentum following a strong close last week and positive Q1 earnings earlier this month. $VCIG (+20.30% | $1.60): No new catalyst today, but the low-float stock is being driven by momentum traders reacting to recent CEO insider buying and speculation around upcoming earnings. $CODX (+20.12% | $6.15): No new catalyst today, but retail momentum continues following last week's announcement regarding the development of an Ebola testing strategy in response to a WHO outbreak alert. $HLIT (+20.07% | $18.25): No new catalyst today, but shares are gapping up on viral social media hype over the weekend highlighting its cOS virtualized cable access platform and strong Q1 earnings.

with the SpaceX IPO inching closer, here's a query worth running: "which sub-$100M market cap companies are most similar to SpaceX based on recent news and filings in the last 6 months?" our agent ran 3 news searches, 3 screener queries, and 2 cross-reference passes, and returned a structured comp table that separates real space-business peers (MNTS, SUUN) from sector-adjacent names (XTIA, ASTC) from above-threshold names already grouped with SpaceX in IPO coverage (FJET, WKEY). this is the work that takes an analyst a full day. our upcoming agent does it in 90 seconds.

point-in-time risk ratings on small-caps didn't exist before. if you've ever wanted to backtest a small-cap risk model, or study chronic diluter patterns. now you can. try it out with our API: askedgar.io/api-pricing

you can now backtest dilution risk against every historical gap going back to April 2021. we just released point-in-time dilution ratings. not "here's the risk today," but "here's what AskEdgar's rating WAS the morning of that 200% pump in 2023." cash need at the time. offering ability at the time. shelf capacity at the time. pending S1 at the time. all snapshotted to the exact date of the gap. now every chronic-diluter setup you've ever traded can be checked against what the model would have told you before you sized in. watch:

what we're building is honestly insane.

Premarket Movers: $PCLA (+172.00% | $6.13): Experiencing a massive retail-driven, low-float momentum squeeze alongside other Japanese micro-caps with no identifiable fundamental news catalyst today. $AKTX (+101.13% | $10.38): Surging on breakthrough ASCO preclinical data for its lead ADC cancer drug and the pricing of a $5.5 million private placement to fund upcoming Phase 1 trials and withdrawing of their S-1 offering yesterday $LFS (+99.47% | $3.75): Spiking following the announced acquisition of Tokai Sports, which immediately adds 1,200 members and 20 facilities to its Japanese youth sports portfolio. $QTEX (+76.89% | $0.54): Running on a recent ticker change (formerly $IINN) and news of advanced strategic collaboration discussions with a top-five global quantum computing company. $HCWB (+30.24% | $3.37): Continuing its earnings-driven momentum after pricing a $4.0 million private placement to advance its clinical-stage immunotherapy pipeline. $GOVX (+29.27% | $3.56): Gaining traction after management highlighted its MVA-based vaccine platform's preclinical protection data amid the escalating Ebola outbreak in Central Africa. $MRM (+26.16% | $1.24): Moving purely on low-float retail momentum in sympathy with other volatile Japanese micro-caps, with no new fundamental catalyst reported. $MTVA (+25.08% | $3.59): Rising on a positive peer-reviewed publication validating the anti-fibrotic potential of its MASH drug candidate, Vanoglipel, ahead of upcoming ADA presentations. $KIDZ (+23.83% | $0.45): Surging on the announcement of a $100 million equity purchase facility to fund a strategic pivot into AI compute infrastructure and a planned rebrand to "KIDZ AI." $RYOJ (+21.39% | $2.46): Caught in a retail-driven, low-float momentum squeeze alongside other Japanese micro-caps without any new fundamental company news.

Premarket Movers: $ATPC (+73.68% | $3.64): No recent catalyst was found, but shares are experiencing extreme low-float volatility and retail-driven momentum (part of the oil/energy theme) $LIMN (+61.98% | $0.30): The company entered into a definitive merger agreement today to acquire InnocsAI LLC, a biotechnology company specializing in CAR-T and antibody-based oncology therapies, for approximately $320 million in stock. $WHLR (+51.13% | $1.41): No recent catalyst was found, but the micro-cap REIT is surging on extreme low-float volatility and retail momentum following recent capital structure simplifications. $RYOJ (+45.41% | $2.87): No recent catalyst was found, but the stock is experiencing a retail-driven, low-float momentum breakout potentially tied to residual AI narrative hype. $SBFM (+44.26% | $0.53): Shares are surging after the company announced today that it received Health Canada regulatory approval for its generic Amoxicillin formulation. $PCLA (+42.85% | $2.00): No recent catalyst was found, but the stock is seeing retail-driven momentum and speculation ahead of an Extraordinary General Meeting scheduled for May 30. $NCPL (+22.58% | $0.56): Shares are continuing their momentum after securing private structured financing earlier this week to support its strategic shift toward AI-powered capital markets infrastructure. $INFQ (+21.74% | $13.63): The company signed a Letter of Intent today with the U.S. Department of Commerce for $100 million in proposed funding to accelerate domestic neutral-atom quantum computing systems. $QUCY (+20.67% | $3.98): The company filed a provisional patent today for its "Quantum Drone Autonomous System" (QDAS) designed to enable GPS-independent navigation and coordinated swarm defense.

this is the exact use case we built the alerts for. real-time news on a small-cap drop, fast enough to actually play the follow-through. nice trade, Alex.

new build on the AskEdgar API: historical gap research dashboard. enter a ticker, see every past gap with the dilution risk, offerings, news, and filings overlaid at the time of each move. built entirely with prompts and our API. open source. youtu.be/NqVTdAq8Oas?si…

Premarket Movers: $SLXN (+143.94% | $0.6570): Shares are surging on retail momentum and speculation following Monday's Q1 update confirming Israeli regulatory approval to initiate a Phase 2/3 trial for its pancreatic cancer drug SIL204. $JUNS (+90.00% | $0.6090): The stock is spiking after signing a term sheet today to acquire exclusive U.S. licensing rights to ALA-002, a next-generation MDMA therapeutic from PharmAla Biotech. $GCL (+85.31% | $0.8027): Shares are rallying following yesterday's announcement of an expanded $10 million strategic investment from ADATA Technology to accelerate global game publishing and digital growth. $MWC (+63.98% | $7.8000): The stock is experiencing extreme post-IPO volatility and retail momentum following its recent Nasdaq debut, with no new fundamental catalyst found today. $PHGE (+41.58% | $0.5316): Shares are running on low-float retail speculation surrounding the company's ongoing strategic pivot from a microbiome biotech to an Israeli defense and AI technology platform. $GDC (+33.10% | $0.1870): Retail traders are aggressively buying based on renewed speculation around a recent $10.75 per share going-private proposal (from earlier this month) and the company's 7,500 Bitcoin holdings. $IMVT (+27.81% | $34.0000): The company reported positive preliminary Week 16 efficacy data today for its IMVT-1402 trial in difficult-to-treat rheumatoid arthritis alongside its Q4 earnings release. $PETZ (+23.46% | $1.0100): The stock is experiencing a classic low-float micro-cap short squeeze driven by retail momentum, though no recent fundamental catalyst was found. $RKDA (+22.97% | $1.1300): Shares are moving on speculative low-float momentum trading continuing from last week's Q1 earnings report, with no new catalyst found today.

Premarket Movers: $AMST (+196.40% | $2.34): Surged following the announcement of its largest-ever enterprise customer win for its NurseMagic™ AI platform, alongside a May 19 10-Q filing showing significant revenue growth and notable insider buying from the CEO and a director. $INM (+190.88% | $1.99): Skyrocketed after announcing a definitive merger agreement with Mentari Therapeutics supported by a $290 million private placement, alongside a May 19 filing detailing a significantly reduced exercise price for preferred investment options. $RUBI (+154.91% | $4.41): Experienced a massive speculative retail momentum squeeze driven by its low-float structure, with no recent fundamental company-specific news or catalysts identified. $WNW (+89.63% | $4.59): Rallied on speculative retail momentum and follow-through buying after a recent $15.65M PIPE raise for its AI skincare platform, though no new fundamental catalyst was found today. $MTVA (+50.47% | $1.68): Gained momentum after announcing three late-breaking poster presentations for its obesity and cardiometabolic assets at the upcoming ADA 2026 Scientific Sessions, supported by a reiterated Buy rating and $20 price target from H.C. Wainwright. $VRAX (+39.70% | $0.33): Popped on retail momentum and increased visibility following a recent Bloomberg TV interview with the CEO discussing Long COVID diagnostics, though no new fundamental catalyst was found today. $MGN (+29.85% | $0.1983): Surged on speculative retail day-trader momentum and technical breakouts on high volume, with no recent fundamental news or catalysts identified. $GIPR (+29.73% | $0.3172): Squeezed higher on speculative retail momentum and short-covering following a recent board refresh, despite recent filings highlighting liquidity concerns and no new positive catalysts found today. $AGYS (+22.48% | $86.50): Jumped after reporting its 17th consecutive record revenue quarter and strong fiscal 2027 guidance, driven by 30.2% subscription revenue growth and the launch of new AI-native software modules.

thanks for the shout @Erik_100x. float data goes back to 2015 right now. coverage varies by endpoint. been great seeing people actually use it. here's the top 20 tickers queried on AskEdgar over the past 24 hours.

Premarket Movers: $SBFM (+614.54% | $2.04): Surging on extreme retail momentum and technical rebound trading following a massive selloff last week from a dilutive offering, with no new fundamental catalyst found today. (somewhat tied to vaccine/virus theme as they had some coronavirus trials a 1-2 years back) $GOVX (+172.36% | $3.35): Rallying after the WHO declared an Ebola outbreak in the DRC and Uganda a global health emergency on May 17, drawing speculative interest to the company's hemorrhagic fever vaccine pipeline. $NXXT (+108.67% | $0.58): Continuing its massive run following Friday's strong Q1 earnings report that showed a 29% revenue increase and tripled gross profits, supported by a corporate update conference call held today. $VRAX (+83.13% | $0.28): Experiencing a momentum-driven retail surge and potential short squeeze following a recent Bloomberg TV interview with the CEO, though no new fundamental catalyst was found today. (part of vaccine/virus theme) $HCAI (+61.55% | $9.02): Moving on speculative, low-float retail momentum following a recent reverse split, with no recent fundamental catalyst found to explain today's action. $AIM (+42.65% | $0.36): Gaining on sympathy momentum from the WHO's Ebola outbreak declaration, as traders highlight the company's pre-clinical Ampligen data showing 100% protection in lethal Ebola mouse models. $CREG (+36.38% | $0.65): Riding continued momentum and short-squeeze interest following Friday's Q1 earnings report that highlighted narrowed losses and 50% gross margins. $HIVE (+31.26% | $3.55): Spiking after announcing plans today to build a massive 320 MW Sovereign AI Infrastructure project in the Greater Toronto Area capable of hosting over 100,000 GPUs. $RAMP (+27.28% | $37.76): Surging after announcing today that it will be acquired by Publicis Groupe in an all-cash deal valued at $38.50 per share, or approximately $2.5 billion. $ZDAI (+22.07% | $1.77): Running on retail day-trading momentum in a low-float micro-cap, with no recent fundamental catalyst found. $LABT (+20.64% | $1.81): Announced positive manufacturing and long-term stability data today for its lead antimicrobial candidate, Nu-3, clearing the way for a planned Phase 2 clinical trial.

the shift is real. we've been seeing the same pattern across our customer base. work that used to take weeks of analyst time on dilution, filings, and risk reads is now finished agent runs by the time the analyst gets back from lunch. the finance industry hasn't fully caught up to AI yet. it is catching up now.

this is what personal software actually looks like. users building their own internal dashboards on top of our data, shaped to exactly how they trade. AskEdgar.

Premarket Movers: $HCWB (+199.70% | $1.01): Shares exploded following the company's first-ever profitable quarter driven by $6.53 million in licensing revenue and a major preclinical breakthrough for its HCW11-040 lung disease treatment. $TDIC (+103.75% | $1.63): The stock continues its massive low-float momentum run driven by retail speculation over a recently announced AI-powered image library platform partnership. $AUUD (+75.41% | $2.15): Shares surged after the company filed its Form S-4 with the SEC today to advance its merger with Thramann Holdings to create a new AI-native platform company. $MRNO (+61.63% | $0.47): The stock is experiencing a low-float, technical momentum squeeze fueled by recent SEC filings revealing that insiders hold over 98% of the outstanding shares. $SLE (+52.09% | $6.21): Shares rallied after the company reported a strong Q1 earnings beat today, highlighting improved gross margins, a debt-free balance sheet, and the strategic acquisition of the Misfits Ads Business. $BIYA (+48.84% | $1.16): This low-float microcap is experiencing a high-volume, momentum-driven technical bounce despite no new fundamental news being released today. $EDBL (+45.39% | $0.60): The stock surged after reporting a 22.9% year-over-year revenue increase in Q1 today, bolstered by an expanding retail partnership with Target. $GEMI (+24.71% | $6.58): Shares jumped following a strong Q1 earnings beat and the announcement of a $100 million strategic investment from Winklevoss Capital Fund priced at a massive premium of $14 per share.

Premarket Movers: $SNAL (+190.78% | $1.46): Surged after reporting a strong Q1 2026 earnings beat with net revenue up 35.7% year-over-year to $27.3 million, driven by the success of its ARK gaming franchise. $YOOV (+97.83% | $1.37): Skyrocketed after announcing today that it secured multi-year contracts exceeding $10 million to deploy its AI-powered integrated security solutions across Singapore. $DXF (+81.53% | $1.38): Continuing its momentum-driven breakout as a highly volatile low-float penny stock following a May 12 company statement addressing unusual market activity, with no new catalysts today. (running as part of the China/Hong Kong theme) $ALP (+72.27% | $0.46): Extending its massive rally following a May 12 announcement of a $32.2 million compute off-take agreement with an AI research lab for its NVIDIA B200 GPU cluster. $AIIO (+63.60% | $4.27): Gaining momentum after its newly acquired subsidiary, Neurovia AI, launched "NeuroStream™" today, a high-fidelity visual data compression platform for edge computing and autonomous systems. $AEHL (+49.17% | $5.42): Experiencing continued speculative momentum in its low-float shares following a May 8 announcement of Bitcoin treasury gains and an upcoming share buyback program. (running as part of the China/Hong Kong theme) $LESL (+32.87% | $1.91): Rallied on a Q2 2026 earnings beat featuring a 4.3% year-over-year sales increase and expanded gross margins driven by a successful "Price Drop" initiative. $QUCY (+32.84% | $1.78): Continuing its explosive run from yesterday's announcement of an exclusive IP license for an autonomous drone "Sky Defense" platform aimed at capitalizing on U.S. defense budget increases. $EDBL (+31.15% | $0.50): Running up on speculative momentum and low-float volatility ahead of its Q1 2026 earnings report scheduled for tomorrow morning. $LNKS (+30.37% | $1.76): Experiencing a technical, low-float short squeeze driven by retail momentum scanners, with no recent fundamental news identified. (running as part of the China/Hong Kong theme) $ONDG (+26.93% | $6.06): Amplifying the post-earnings surge of Ondas Inc., which reported record Q1 revenue of $50.1 million and raised its FY2026 guidance today. $IPHA (+24.24% | $1.64): Gaining on a positive Q1 2026 business update highlighting clinical progress and FDA clearance to initiate the Phase 3 TELLOMAK-3 trial for lacutamab. $GTBP (+23.73% | $0.39): Moving on technical momentum and speculative buying ahead of its upcoming Q1 2026 earnings report, with no new fundamental news today. $POET (+21.36% | $17.44): Announced a strategic partnership and supply agreement with Lumilens today for AI photonics optical engines, backed by an initial $50 million purchase order.

look at this. a user just built this. every ticker in the top gainers feed comes with a full risk read. cash runway, float, market cap, sector, and underwriter pattern matching. AC Sunshine flagged as a known China P&D underwriter. all custom. built on AskEdgar API.

Premarket Movers: $QUCY (+85.87% | $0.60): Shares surged after announcing an exclusive IP license agreement with BP United to acquire and deploy autonomous drone technology, aligning with increased U.S. defense spending. $FCHL (+42.83% | $1.90): Experiencing a speculative low-float short squeeze following a recent 1-for-15 reverse split, though no recent company-specific catalyst was found today. $TDIC (+28.81% | $3.05): Continuing its momentum from yesterday's announcement of a non-binding MoU with LinkFung Innovation to co-develop an AI-powered intelligent image library platform. $EOSE (+28.27% | $10.39): Crushed Q1 earnings with a 445% year-over-year revenue increase and announced the formation of the Frontier Power USA joint venture with Cerberus Capital Management. $AEHL (+27.49% | $2.70): Riding continued momentum from last week's announcement of realized Bitcoin treasury gains and an upcoming share repurchase program. $VELO (+24.25% | $17.47): Delivered a strong Q1 earnings beat featuring 48% year-over-year revenue growth, improved margins, and a new $9.8 million defense contract. $OCG (+23.12% | $2.29): Running on a speculative low-float momentum squeeze following a recent reverse split and the termination of its ATM offering, though no new catalyst was found today $SLS (+20.50% | $6.31): Rallied after its Q1 corporate update revealed the company is just two events away from triggering the final analysis of its pivotal Phase 3 REGAL trial for acute myeloid leukemia.